
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (14): 1766-1774.DOI: 10.12114/j.issn.1007-9572.2022.0788
Special Issue: 神经退行性病变最新文章合辑; 帕金森最新文章合辑; 脑健康最新研究合辑
• Evidence-based Medicine • Previous Articles Next Articles
Received:2022-05-06
Revised:2022-12-02
Published:2023-05-15
Online:2022-12-29
Contact:
XU Guihua
通讯作者:
徐桂华
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0788
| 步骤 | 检索式 |
|---|---|
| #1 | ALL=(Parkinson's disease) OR ALL=(parkinsonism) |
| #2 | ALL=(dangerous factor) OR ALL=(risk factor) OR ALL=(relevant factor) OR ALL=(relative factor) OR ALL=(correlative factor) OR ALL=(impact factor) OR ALL=(contributing factor) OR ALL=(associated factor) OR ALL=(predictive factor) OR ALL=(affecting factor) |
| #3 | ALL=(ache) OR ALL=(pain) OR ALL=(douleur) |
| #4 | #1 AND #2 AND #3 |
Table 1 Strategy for searching literature on factors influencing pain in patients with Parkinson's disease
| 步骤 | 检索式 |
|---|---|
| #1 | ALL=(Parkinson's disease) OR ALL=(parkinsonism) |
| #2 | ALL=(dangerous factor) OR ALL=(risk factor) OR ALL=(relevant factor) OR ALL=(relative factor) OR ALL=(correlative factor) OR ALL=(impact factor) OR ALL=(contributing factor) OR ALL=(associated factor) OR ALL=(predictive factor) OR ALL=(affecting factor) |
| #3 | ALL=(ache) OR ALL=(pain) OR ALL=(douleur) |
| #4 | #1 AND #2 AND #3 |
| 第一作者 | 发表年份(年) | 国家/地区 | 研究类型 | 样本量(例) | 疼痛评估工具或诊断方法 | 疼痛发生率(%) | 影响因素 |
|---|---|---|---|---|---|---|---|
| 郭志颖[ | 2022 | 中国南京 | 病例对照研究 | 129 | UPDRS Ⅱ第17项 | 31.78 | ①③④⑤⑥⑦⑧ |
| LI[ | 2022 | 中国合肥 | 横断面研究 | 452 | NRS | 45.58 | ①⑨ |
| 邢峰博[ | 2021 | 中国合肥 | 横断面研究 | 106 | KPPS | 50.00 | ⑩ |
| 唐佳[ | 2021 | 中国昆明 | 横断面研究 | 88 | 按国际疼痛协会定义 | 39.80 | ③⑥⑪ |
| 李晓涵[ | 2021 | 中国长春 | 横断面研究 | 86 | KPPS | 65.38 | ①⑥⑧⑫ |
| 孙海华[ | 2020 | 中国盐城 | 病例对照研究 | 81 | 简易疼痛问卷 | 48.15 | ⑥⑦⑧ |
| 刘育栋[ | 2020 | 中国南昌 | 横断面研究 | 105 | VAS评分 | 61.90 | ⑭⑮⑯ |
| GHOSH[ | 2020 | 美国、意大利 | 横断面研究 | 167 | KPPS、BPI | 88.00 | ①⑬(24) |
| 李耀[ | 2019 | 中国徐州 | 横断面研究 | 128 | VAS评分 | 49.20 | ⑥ |
| JOSEPH[ | 2019 | 瑞典 | 横断面研究 | 100 | Short Form(SF) -36 | 80.00 | ③⑰⑱ |
| RODRÍGUEZ-VIOLANTE[ | 2017 | 墨西哥 | 横断面研究 | 341 | KPPS | 88.60 | ①⑥⑬⑲ |
| OZTURK[ | 2016 | 土耳其 | 横断面研究 | 113 | VAS评分 | 64.60 | ①⑥⑳(21) |
| 张晓艺[ | 2014 | 中国苏州 | 横断面研究 | 343 | VAS评分 | 47.80 | ⑥ |
| 杨芬[ | 2014 | 中国北京 | 横断面研究 | 92 | 简易疼痛问卷、VAS | 52.20 | ⑥⑦ |
| 戴云涛[ | 2012 | 中国北京 | 横断面研究 | 74 | 简易疼痛问卷 | 23.00 | ①② |
| NÈGRE-PAGÈS[ | 2008 | 法国 | 横断面研究 | 450 | 麦吉尔疼痛问卷 | 61.80 | ⑥(22)(23) |
Table 2 General characteristics of studies on factors affecting pain in Parkinson's disease patients
| 第一作者 | 发表年份(年) | 国家/地区 | 研究类型 | 样本量(例) | 疼痛评估工具或诊断方法 | 疼痛发生率(%) | 影响因素 |
|---|---|---|---|---|---|---|---|
| 郭志颖[ | 2022 | 中国南京 | 病例对照研究 | 129 | UPDRS Ⅱ第17项 | 31.78 | ①③④⑤⑥⑦⑧ |
| LI[ | 2022 | 中国合肥 | 横断面研究 | 452 | NRS | 45.58 | ①⑨ |
| 邢峰博[ | 2021 | 中国合肥 | 横断面研究 | 106 | KPPS | 50.00 | ⑩ |
| 唐佳[ | 2021 | 中国昆明 | 横断面研究 | 88 | 按国际疼痛协会定义 | 39.80 | ③⑥⑪ |
| 李晓涵[ | 2021 | 中国长春 | 横断面研究 | 86 | KPPS | 65.38 | ①⑥⑧⑫ |
| 孙海华[ | 2020 | 中国盐城 | 病例对照研究 | 81 | 简易疼痛问卷 | 48.15 | ⑥⑦⑧ |
| 刘育栋[ | 2020 | 中国南昌 | 横断面研究 | 105 | VAS评分 | 61.90 | ⑭⑮⑯ |
| GHOSH[ | 2020 | 美国、意大利 | 横断面研究 | 167 | KPPS、BPI | 88.00 | ①⑬(24) |
| 李耀[ | 2019 | 中国徐州 | 横断面研究 | 128 | VAS评分 | 49.20 | ⑥ |
| JOSEPH[ | 2019 | 瑞典 | 横断面研究 | 100 | Short Form(SF) -36 | 80.00 | ③⑰⑱ |
| RODRÍGUEZ-VIOLANTE[ | 2017 | 墨西哥 | 横断面研究 | 341 | KPPS | 88.60 | ①⑥⑬⑲ |
| OZTURK[ | 2016 | 土耳其 | 横断面研究 | 113 | VAS评分 | 64.60 | ①⑥⑳(21) |
| 张晓艺[ | 2014 | 中国苏州 | 横断面研究 | 343 | VAS评分 | 47.80 | ⑥ |
| 杨芬[ | 2014 | 中国北京 | 横断面研究 | 92 | 简易疼痛问卷、VAS | 52.20 | ⑥⑦ |
| 戴云涛[ | 2012 | 中国北京 | 横断面研究 | 74 | 简易疼痛问卷 | 23.00 | ①② |
| NÈGRE-PAGÈS[ | 2008 | 法国 | 横断面研究 | 450 | 麦吉尔疼痛问卷 | 61.80 | ⑥(22)(23) |
| 第一作者 | ① | ② | ③ | ④ | ⑤ | ⑥ | ⑦ | ⑧ | ⑨ | ⑩ | ⑪ | 总分 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LI[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 8 |
| 邢峰博[ | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 6 |
| 唐佳[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 8 |
| 李晓涵[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 9 |
| 刘育栋[ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 9 |
| GHOSH[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 7 |
| 李耀[ | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 6 |
| JOSEPH[ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 8 |
| RODRÍGUEZ-VIOLANTE[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 7 |
| OZTURK[ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 8 |
| 张晓艺[ | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 7 |
| 杨芬[ | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 6 |
| 戴云涛[ | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 6 |
| NÈGRE-PAGÈS[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 8 |
Table 3 Quality assessment of cross-sectional studies on influencing factors of pain in Parkinson's disease patients
| 第一作者 | ① | ② | ③ | ④ | ⑤ | ⑥ | ⑦ | ⑧ | ⑨ | ⑩ | ⑪ | 总分 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LI[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 8 |
| 邢峰博[ | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 6 |
| 唐佳[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 8 |
| 李晓涵[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 9 |
| 刘育栋[ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 9 |
| GHOSH[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 7 |
| 李耀[ | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 6 |
| JOSEPH[ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 8 |
| RODRÍGUEZ-VIOLANTE[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 7 |
| OZTURK[ | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 8 |
| 张晓艺[ | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 7 |
| 杨芬[ | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 6 |
| 戴云涛[ | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 6 |
| NÈGRE-PAGÈS[ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 8 |
| 第一作者 | 研究人群选择 | 组间可比性设计和统计分析时考虑病例和对照的可比性 | 暴露因素测量 | 总分 | |||||
|---|---|---|---|---|---|---|---|---|---|
| 病例确定是否恰当 | 病例代表性 | 对照选择 | 对照确定 | 暴露因素的确定 | 采用相同方法确定病例和对照组暴露因素 | 无应答率 | |||
| 郭志颖[ | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 8 |
| 孙海华[ | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 8 |
Table 4 Quality assessment of case-control studies on influencing factors of pain in Parkinson's disease patients
| 第一作者 | 研究人群选择 | 组间可比性设计和统计分析时考虑病例和对照的可比性 | 暴露因素测量 | 总分 | |||||
|---|---|---|---|---|---|---|---|---|---|
| 病例确定是否恰当 | 病例代表性 | 对照选择 | 对照确定 | 暴露因素的确定 | 采用相同方法确定病例和对照组暴露因素 | 无应答率 | |||
| 郭志颖[ | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 8 |
| 孙海华[ | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 8 |
| 相关因素 | 保护因素 | 危险因素 |
|---|---|---|
| 社会人口学 | ||
| 性别 | — | 3[ |
| 年龄 | — | 1[ |
| PD情况 | ||
| 病程 | — | 3[ |
| Hoehn-Yahr分级 | — | 3[ |
| 发病年龄 | — | 1[ |
| 用药情况 | ||
| 左旋多巴等效日剂量 | — | 1[ |
| 共病情况 | ||
| 心血管障碍 | — | 1[ |
| 实验室检查 | ||
| 中缝核回声变化 | — | 1[ |
| MMSE评分 | 高[ | — |
| MoCa评分 | 高[ | — |
| 抑郁情绪评分 | — | 10[ |
| UPDRSⅡ评分 | — | 1[ |
| UPDRSⅢ评分 | — | 3[ |
| UPDRSⅣ评分 | — | 1[ |
| FS-14评分 | — | 1[ |
| PDSS-2评分 | — | 1[ |
| NMSS评分 | — | 2[ |
| PSQI睡眠质量评分 | — | 1[ |
| PD相关症状 | ||
| 运动亚型 | — | 1[ |
| 运动波动 | — | 1[ |
| 强直 | — | 1[ |
| 其他 | ||
| 易患疼痛的医疗状况 | — | 1[ |
| 平衡性 | — | 1[ |
| 与健康相关的生活质量 | — | 1[ |
Table 5 Descriptive analysis of influencing factors of pain in Parkinson's disease patients
| 相关因素 | 保护因素 | 危险因素 |
|---|---|---|
| 社会人口学 | ||
| 性别 | — | 3[ |
| 年龄 | — | 1[ |
| PD情况 | ||
| 病程 | — | 3[ |
| Hoehn-Yahr分级 | — | 3[ |
| 发病年龄 | — | 1[ |
| 用药情况 | ||
| 左旋多巴等效日剂量 | — | 1[ |
| 共病情况 | ||
| 心血管障碍 | — | 1[ |
| 实验室检查 | ||
| 中缝核回声变化 | — | 1[ |
| MMSE评分 | 高[ | — |
| MoCa评分 | 高[ | — |
| 抑郁情绪评分 | — | 10[ |
| UPDRSⅡ评分 | — | 1[ |
| UPDRSⅢ评分 | — | 3[ |
| UPDRSⅣ评分 | — | 1[ |
| FS-14评分 | — | 1[ |
| PDSS-2评分 | — | 1[ |
| NMSS评分 | — | 2[ |
| PSQI睡眠质量评分 | — | 1[ |
| PD相关症状 | ||
| 运动亚型 | — | 1[ |
| 运动波动 | — | 1[ |
| 强直 | — | 1[ |
| 其他 | ||
| 易患疼痛的医疗状况 | — | 1[ |
| 平衡性 | — | 1[ |
| 与健康相关的生活质量 | — | 1[ |
| 结局指标 | 研究数量(篇) | 偏倚风险 | 不一致性 | 不精确性 | 间接性 | 发表偏倚 | 总样本量(例) | RR(95%CI) | 证据质量 |
|---|---|---|---|---|---|---|---|---|---|
| 性别 | 7 | 不严重 | 严重b | 不严重 | 不严重 | 无 | 1 283 | 3.73(1.75,7.96) | 中 |
| 病程 | 3 | 严重a | 不严重 | 严重c | 不严重 | 无 | 317 | 1.35(1.15,1.60) | 低 |
| 抑郁情绪 | 10 | 严重a | 不严重 | 严重c | 不严重 | 无 | 1 851 | 1.14(1.07,1.22) | 低 |
| UPDRSⅢ评分 | 3 | 严重a | 不严重 | 严重c | 不严重 | 无 | 302 | 1.07(1.03,1.11) | 低 |
| Hoehn-Yahr分级 | 3 | 严重a | 不严重 | 不严重 | 不严重 | 无 | 296 | 2.28(1.28,4.04) | 极低 |
| NMSS评分 | 2 | 严重a | 不严重 | 不严重 | 不严重 | 无 | 508 | 1.68(1.46,1.93) | 中 |
Table 6 Evaluation of the quality of evidence rated by GRADE in the included literature
| 结局指标 | 研究数量(篇) | 偏倚风险 | 不一致性 | 不精确性 | 间接性 | 发表偏倚 | 总样本量(例) | RR(95%CI) | 证据质量 |
|---|---|---|---|---|---|---|---|---|---|
| 性别 | 7 | 不严重 | 严重b | 不严重 | 不严重 | 无 | 1 283 | 3.73(1.75,7.96) | 中 |
| 病程 | 3 | 严重a | 不严重 | 严重c | 不严重 | 无 | 317 | 1.35(1.15,1.60) | 低 |
| 抑郁情绪 | 10 | 严重a | 不严重 | 严重c | 不严重 | 无 | 1 851 | 1.14(1.07,1.22) | 低 |
| UPDRSⅢ评分 | 3 | 严重a | 不严重 | 严重c | 不严重 | 无 | 302 | 1.07(1.03,1.11) | 低 |
| Hoehn-Yahr分级 | 3 | 严重a | 不严重 | 不严重 | 不严重 | 无 | 296 | 2.28(1.28,4.04) | 极低 |
| NMSS评分 | 2 | 严重a | 不严重 | 不严重 | 不严重 | 无 | 508 | 1.68(1.46,1.93) | 中 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
曾宪涛,刘慧,陈曦,等. Meta分析系列之四:观察性研究的质量评价工具[J]. 中国循证心血管医学杂志,2012,4(4):297-299. DOI:10.3969/j.1674-4055.2012.04.004.
|
| [5] |
杨慧锋,牛伟华,施月仙,等. 慢性心力衰竭患者发生认知功能障碍影响因素的系统评价[J]. 中国全科医学,2022,25(13):1642-1650. DOI:10.12114/j.issn.1007-9572.2022.0053.
|
| [6] |
|
| [7] |
尹丽达,王佳森,贺永超,等. 现场第一反应者早期除颤对院外心脏骤停患者存活率影响的Meta分析[J]. 中国全科医学,2022,25(14):1757-1764. DOI:10.12114/j.issn.1007-9572.2022.01.604.
|
| [8] |
郭志颖,刘卫国,孙钰,等. 初诊帕金森病患者疼痛相关危险因素分析[J]. 中国现代神经疾病杂志,2022,22(3):173-178.
|
| [9] |
|
| [10] |
邢峰博,章娟娟,汪凯,等. 帕金森病患者的疼痛特征及转归[J]. 中华神经科杂志,2021,54(11):1155-1161. DOI:10.3760/cma.j.cn113694-20210203-00091.
|
| [11] |
唐佳. 帕金森病疼痛患者的临床特征及基于KPPS对帕金森病疼痛分类的初步探究[D]. 昆明:昆明医科大学,2021.
|
| [12] |
李晓涵. 帕金森病伴发疼痛的影响因素研究[D]. 长春:吉林大学,2021.
|
| [13] |
孙海华,肖佩荣. PD患者疼痛的相关危险因素分析[J]. 现代医学与健康研究(电子版),2020,4(17):109-110.
|
| [14] |
刘育栋. 帕金森病伴慢性疼痛的临床特点及危险因素分析[D]. 南昌:南昌大学,2020.
|
| [15] |
|
| [16] |
李耀,祖洁,董丽果,等. 帕金森病伴疼痛的临床特点及相关因素[J]. 中国神经免疫学和神经病学杂志,2019,26(4):265-268,280. DOI:10.3969/j.issn.1006-2963.2019.04.006.
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
张晓芝. 帕金森病伴慢性疼痛患者的临床特征及认知功能的相关性分析[D]. 苏州:苏州大学,2014.
|
| [21] |
杨芬,张英谦,吕强,等. 帕金森病患者伴发疼痛的特点及其相关因素的研究[J]. 临床神经病学杂志,2014,27(2):94-96.
|
| [22] |
戴云涛. 帕金森病伴慢性疼痛与抑郁症的发病率及其相关性分析[D]. 中国医科大学,2012.
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [1] | LI Jiawei, GAO Xinyi, GE Aoqi, LI Juanjuan, YUAN Beibei. Demand and Associated Factors for Integrated Medical Care and Preventive Services among Patients with Type 2 Diabetes [J]. Chinese General Practice, 2026, 29(21): 3028-3039. |
| [2] | LI Feng, HU Changhao, LUO Xu. Progress in the Study of Influencing Factors and Intervention Strategies of Mental Health in Elderly Patients with Multiple Chronic Conditions [J]. Chinese General Practice, 2026, 29(20): 2816-2828. |
| [3] | TANG Lijuan, QI Qi, ZHANG Fan, GAO Yifu, CAO Yajing, YUE Fujuan, GAO Jinchai, LIU Xiaoli. Characterisation of the Prevalence of Overweight/Obesity among Residents Aged 18-44 Years in Hebei Province in 2013 and 2020 [J]. Chinese General Practice, 2026, 29(19): 2695-2704. |
| [4] | ZHANG Huifang, CHEN Cunchuan, FAN Boyang, SUN Wenning, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study on the Service Capability of Primary Care Doctors to Integrate Medical and Preventive Services and Its Influencing Factors in Shandong Province [J]. Chinese General Practice, 2026, 29(19): 2711-2716. |
| [5] | JIANG Quanrui, FENG Xiang, LIU Dan, LI Tao, YANG Zhou, LI Jiangshan, LIU Xiaowei, LI Wu. Effects of Pressing Intervention on Myofascial Trigger Points in Rats Based on cAMP/PKA/P-RyR1 and Intracellular Ca2+ Content [J]. Chinese General Practice, 2026, 29(18): 2513-2522. |
| [6] | LIU Fang, LIU Weinan, XIANG Yuanyue, LU Cheng, ZHU Binhai. Factors Influencing Work-related Flow among "3+2" Order-oriented Assistant General Practitioners in Jiangsu Province [J]. Chinese General Practice, 2026, 29(18): 2454-2460. |
| [7] | LUO Yutong, LI Jing. The HPV Vaccine Coverage and Its Influencing Factors among the Eligible Population in China Based on a Geographically Weighted Regression Model [J]. Chinese General Practice, 2026, 29(16): 2234-2243. |
| [8] | ZHENG Zelu, ZHOU Jun, LIANG Zhi, WANG Xuehui, XU Feng, LI Oujing, XIAO Hong, LIU Xiaoyu, YANG Qingmei, ZHANG Mei, LIN Na, MI Baohong, CHEN Weiheng. Comorbidity Profiles and Treatment Patterns of Osteoarthritis Patients: a Cross-sectional Study Based on Community Medical Records [J]. Chinese General Practice, 2026, 29(16): 2205-2213. |
| [9] | WANG Yang, JIN Hua, YANG Sen, YANG Hui, YU Dehua. Reconfiguring the Functional Features of Primary Care in a Non-gatekeeping Context: a 15-Year Mixed-methods Systematic Review from China [J]. Chinese General Practice, 2026, 29(16): 2140-2155. |
| [10] | LI Jiawei, GE Aoqi, GAO Xinyi, LI Juanjuan, YUAN Beibei. The Concept, Connotation, and Pathways of the Integration of Medical Care and Preventive Services in China: a Systematic Review [J]. Chinese General Practice, 2026, 29(16): 2156-2166. |
| [11] | CHEN Yan, SHEN Dequan, SHENG Renlei, CHANG Yujie, YANG Jiaqi, DING Jie, SUN Zhifang, WANG Dahui. Influencing Factors and Importance Ranking of the Utilization of Primary-level Traditional Chinese Medicine Preventive and Health Care Services for the Elderly [J]. Chinese General Practice, 2026, 29(16): 2182-2189. |
| [12] | CHEN Bihua, LIN Qiyi, LI Wuhua, SU Jin, TU Liping, SHI Lan, DING Xiaoqin, YI Chuntao. The Influencing Factors and Mechanisms of the Work Output Level of Family Doctor Teams from the Perspective of Team Effectiveness [J]. Chinese General Practice, 2026, 29(16): 2167-2173. |
| [13] | YU Chao, SONG Lihua, WANG Linyan, LU Yunping, WANG Linyang, CUI Wei. The Functional Outcomes and Influencing Factors in Patients with First-episode Major Depressive Disorder after 7 Years [J]. Chinese General Practice, 2026, 29(16): 2221-2226. |
| [14] | YU Shan, CHE Yajie, SUBIYINUER· Maimaiti, GUO Kaiyang, FENG Xingxing, YAN Ping. A Comparative Study on the Current Situation and Influencing Factors of Subjective Cognitive Decline among Urban and Rural Elderly People in Xinjiang [J]. Chinese General Practice, 2026, 29(16): 2227-2233. |
| [15] | FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||